Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.

Human iPSC-liver organoid transplantation reduces fibrosis through immunomodulation

Abstract

Donor organ shortages for transplantation remain a serious global concern, and alternative treatment is in high demand. Fetal cells and tissues have considerable therapeutic potential as, for example, organoid technology that uses human induced pluripotent stem cells (hiPSCs) to generate unlimited human fetal-like cells and tissues. We previously reported the in vivo vascularization of early fetal liver–like hiPSC-derived liver buds (LBs) and subsquent improved survival of recipient mice with subacute liver failure. Here, we show hiPSC–liver organoids (LOs) that recapitulate midgestational fetal liver promote de novo liver generation when grafted onto the surface of host livers in chemical fibrosis models, thereby recovering liver function. We found that fetal liver, a hematopoietic tissue, highly expressed macrophage-recruiting factors and antifibrotic M2 macrophage polarization factors compared with the adult liver, resulting in fibrosis reduction because of CD163 + M2-macrophage polarization. Next, we created midgestational fetal liver–like hiPSC-LOs by fusion of hiPSC-LBs to induce static cell-cell interactions and found that these contained complex structures such as hepatocytes, vasculature, and bile ducts after transplantation. This fusion allowed the generation of a large human tissue suitable for transplantation into immunodeficient rodent models of liver fibrosis. hiPSC-LOs showed superior liver function compared with hiPSC-LBs and improved survival and liver function upon transplantation. In addition, hiPSC-LO transplantation ameliorated chemically induced liver fibrosis, a symptom of liver cirrhosis that leads to organ dysfunction, through immunomodulatory effects, particularly on CD163 + phagocytic M2-macrophage polarization. Together, our results suggest hiPSC-LO transplantation as a promising therapeutic option for liver fibrosis.

Overview

Integrity signals

Registry

Crossref · 10.1126/scitranslmed.adg0338

Cites

54 of 54 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 54 references

Cited by

See all 58

Metadata

Authors
Tadokoro, T., Murata, S., Kato, M., Ueno, Y., Tsuchida, T., Okumura, A., Kuse, Y., Konno, T., Uchida, Y., Yamakawa, Y., Zushi, M., Yajima, M., Kobayashi, T., Hasegawa, S., Kawakatsu-Hatada, Y., Hayashi, Y., Osakabe, S., Maeda, T., Kimura, K., Mori, A., Tanaka, M., Kamishibahara, Y., Matsuo, M., Nie, Y.-Z., Okamoto, S., Oba, T., Tanimizu, N., & Taniguchi, H.
Affiliations
  • Institute of Medical Science, The University of Tokyo (JP)
  • Yokohama City University (JP)
  • Department of Regenerative Medicine, Yokohama City University School of Medicine, Yokohama, Kanagawa 236-0004, Japan.
Corresponding author
  • Tadokoro, Tomomi
  • Taniguchi, Hideki
Venue
Science Translational Medicine
Published
2024-07-24
Volume
16
Issue
757
Pages
eadg0338-eadg0338
ISSN
  • 1946-6234 (ISSN-L)
  • 1946-6242
OpenAlex
W4400945382
Cited by
58
References
54
Citations by year
2026: 24 · 2025: 31 · 2024: 3
FWCI
14.99
Type
journal article
Language
en
Open access
closed
Locations
  • Science Translational Medicine (publishedVersion)
  • PubMed (publishedVersion)
Funders
Japan Society for the Promotion of Science (23K08053, 22K08807)
Topics
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
  • Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
Keywords
human induced pluripotent stem cells, liver organoids, liver fibrosis, liver transplantation, M2 macrophage polarization, CD163, immunomodulation, cell fusion, liver cirrhosis, hepatocyte differentiation, vascularization
MeSH terms
Animals, Humans, Liver, Liver Cirrhosis, Macrophages, Organoids, Liver Transplantation, Mice, Immunomodulation, Induced Pluripotent Stem Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Human iPSC-liver organoid transplantation reduces fibrosis through immunomodulation. https://app.cochat.ai/papers/10.1126/scitranslmed.adg0338
The paper
Tadokoro, T., Murata, S., Kato, M., Ueno, Y., Tsuchida, T., Okumura, A., Kuse, Y., Konno, T., Uchida, Y., Yamakawa, Y., Zushi, M., Yajima, M., Kobayashi, T., Hasegawa, S., Kawakatsu-Hatada, Y., Hayashi, Y., Osakabe, S., Maeda, T., Kimura, K., . . . Taniguchi, H. (2024). Human iPSC-liver organoid transplantation reduces fibrosis through immunomodulation. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.adg0338

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.